Adecto Pharmaceuticals

Adecto Pharmaceuticals

Company Details

WebsiteLinkedIn

Status: Private

Employees: 1-10

Location:

Boston, Massachusetts, United States

Type:

sample

Technology:

sample

sample

sample

About: Adecto is a pre-clinical stage, cancer therapeutics company, developing the first targeted therapy against ADAM8-expressing cancers and a companion diagnostic to identify patients who can benefit from it. ADAM8 is a critical driver of the growth and spread of many aggressive tumors, including those of the breast, stomach, colon, lungs, liver and pancreas, and is associated with poor patient survival. Adecto’s current focus is on breast cancer with a plan to expand to other oncology indications in the future.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
BiopharmIQ
Adecto Pharmaceuticals | Active clinical trials on ClinicalTrials.gov

Active Clinical Trials Count | 0

No Active Trials Found On ClinicalTrials.gov.